Annual Long Term Debt
$34.22 M
-$8.84 M-20.52%
December 31, 2023
Summary
- As of February 7, 2025, IPHA annual long term debt is $34.22 million, with the most recent change of -$8.84 million (-20.52%) on December 31, 2023.
- During the last 3 years, IPHA annual long term debt has risen by +$13.38 million (+64.19%).
- IPHA annual long term debt is now -20.52% below its all-time high of $43.06 million, reached on December 31, 2022.
Performance
IPHA Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$28.48 M
-$5.74 M-16.76%
June 30, 2024
Summary
- As of February 7, 2025, IPHA quarterly long term debt is $28.48 million, with the most recent change of -$5.74 million (-16.76%) on June 30, 2024.
- Over the past year, IPHA quarterly long term debt has dropped by -$9.90 million (-25.80%).
- IPHA quarterly long term debt is now -33.84% below its all-time high of $43.06 million, reached on December 31, 2022.
Performance
IPHA Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
IPHA Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -20.5% | -25.8% |
| 3 y3 years | +64.2% | -25.8% |
| 5 y5 years | +842.2% | -25.8% |
IPHA Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -20.5% | +123.8% | -33.8% | +117.8% |
| 5 y | 5-year | -20.5% | +123.8% | -33.8% | +117.8% |
| alltime | all time | -20.5% | +899.4% | -33.8% | +731.9% |
Innate Pharma SA Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2024 | - | $28.48 M(-16.8%) |
| Dec 2023 | $34.22 M(-20.5%) | $34.22 M(-10.9%) |
| Jun 2023 | - | $38.39 M(-10.8%) |
| Dec 2022 | $43.06 M(+181.6%) | $43.06 M(+229.1%) |
| Jun 2022 | - | $13.08 M(-14.4%) |
| Dec 2021 | $15.29 M(-26.6%) | $15.29 M(-11.3%) |
| Jun 2021 | - | $17.24 M(-17.3%) |
| Dec 2020 | $20.84 M(+12.1%) | $20.84 M(+10.4%) |
| Jun 2020 | - | $18.87 M(+1.5%) |
| Dec 2019 | $18.59 M(+411.8%) | $18.59 M(+405.0%) |
| Jun 2019 | - | $3.68 M(+1.3%) |
| Dec 2018 | $3.63 M(-33.0%) | $3.63 M(-19.0%) |
| Jun 2018 | - | $4.48 M(-17.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $5.42 M(+26.3%) | $5.42 M(+37.1%) |
| Jun 2017 | - | $3.96 M(-7.9%) |
| Dec 2016 | $4.30 M(+25.4%) | $4.30 M(+19.5%) |
| Jun 2016 | - | $3.60 M(+5.0%) |
| Dec 2015 | $3.42 M(-25.0%) | $3.42 M(-13.3%) |
| Jun 2015 | - | $3.95 M(-13.5%) |
| Dec 2014 | $4.56 M(-21.4%) | $4.56 M(-16.0%) |
| Jun 2014 | - | $5.43 M(-6.5%) |
| Dec 2013 | $5.81 M(+32.0%) | $5.81 M(+52.3%) |
| Jun 2013 | - | $3.81 M(-13.3%) |
| Dec 2012 | $4.40 M(-24.5%) | $4.40 M(-24.5%) |
| Dec 2011 | $5.83 M(-46.1%) | $5.83 M(-46.1%) |
| Dec 2009 | $10.80 M(+21.4%) | $10.80 M |
| Dec 2008 | $8.90 M | - |
FAQ
- What is Innate Pharma SA annual long term debt?
- What is the all time high annual long term debt for Innate Pharma SA?
- What is Innate Pharma SA annual long term debt year-on-year change?
- What is Innate Pharma SA quarterly long term debt?
- What is the all time high quarterly long term debt for Innate Pharma SA?
- What is Innate Pharma SA quarterly long term debt year-on-year change?
What is Innate Pharma SA annual long term debt?
The current annual long term debt of IPHA is $34.22 M
What is the all time high annual long term debt for Innate Pharma SA?
Innate Pharma SA all-time high annual long term debt is $43.06 M
What is Innate Pharma SA annual long term debt year-on-year change?
Over the past year, IPHA annual long term debt has changed by -$8.84 M (-20.52%)
What is Innate Pharma SA quarterly long term debt?
The current quarterly long term debt of IPHA is $28.48 M
What is the all time high quarterly long term debt for Innate Pharma SA?
Innate Pharma SA all-time high quarterly long term debt is $43.06 M
What is Innate Pharma SA quarterly long term debt year-on-year change?
Over the past year, IPHA quarterly long term debt has changed by -$9.90 M (-25.80%)